Annual D&A
$1.60 M
+$215.00 K+15.56%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual depreciation & amortization is $1.60 million, with the most recent change of +$215.00 thousand (+15.56%) on December 31, 2023.
- During the last 3 years, OVID annual D&A has risen by +$1.29 million (+420.40%).
- OVID annual D&A is now at all-time high.
Performance
OVID Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$169.00 K
+$287.00 K+243.22%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly depreciation & amortization is $169.00 thousand, with the most recent change of +$287.00 thousand (+243.22%) on September 30, 2024.
- Over the past year, OVID quarterly D&A has dropped by -$999.60 thousand (-85.54%).
- OVID quarterly D&A is now -85.54% below its all-time high of $1.17 million, reached on December 31, 2023.
Performance
OVID Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.62 M
+$23.00 K+1.44%
September 30, 2024
Summary
- As of February 8, 2025, OVID TTM depreciation & amortization is $1.62 million, with the most recent change of +$23.00 thousand (+1.44%) on September 30, 2024.
- Over the past year, OVID TTM D&A has increased by +$25.00 thousand (+1.57%).
- OVID TTM D&A is now -4.94% below its all-time high of $1.71 million, reached on March 31, 2023.
Performance
OVID TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
OVID Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.6% | -85.5% | +1.6% |
| 3 y3 years | +420.4% | -85.5% | +1.6% |
| 5 y5 years | +1026.8% | -85.5% | +1.6% |
OVID Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +573.4% | -85.5% | +243.2% | -4.9% | +586.5% |
| 5 y | 5-year | at high | +573.4% | -85.5% | +243.2% | -4.9% | +586.5% |
| alltime | all time | at high | >+9999.0% | -85.5% | +243.2% | -4.9% | >+9999.0% |
Ovid Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $169.00 K(-243.2%) | $1.62 M(+1.4%) |
| Jun 2024 | - | -$118.00 K(-129.4%) | $1.60 M(-0.1%) |
| Mar 2024 | - | $402.00 K(-65.6%) | $1.60 M(+0.3%) |
| Dec 2023 | $1.60 M(+15.6%) | $1.17 M(+700.4%) | $1.60 M(+83.9%) |
| Sep 2023 | - | $146.00 K(-225.9%) | $868.00 K(-23.7%) |
| Jun 2023 | - | -$116.00 K(-129.1%) | $1.14 M(-33.3%) |
| Mar 2023 | - | $398.00 K(-9.5%) | $1.71 M(+23.5%) |
| Dec 2022 | $1.38 M(+482.7%) | $440.00 K(+5.9%) | $1.38 M(+38.3%) |
| Sep 2022 | - | $415.40 K(-8.2%) | $998.70 K(+57.2%) |
| Jun 2022 | - | $452.50 K(+513.1%) | $635.50 K(+169.1%) |
| Mar 2022 | - | $73.80 K(+29.5%) | $236.20 K(-0.4%) |
| Dec 2021 | $237.10 K(-22.7%) | $57.00 K(+9.2%) | $237.10 K(-9.9%) |
| Sep 2021 | - | $52.20 K(-1.9%) | $263.10 K(-9.2%) |
| Jun 2021 | - | $53.20 K(-28.8%) | $289.80 K(-7.9%) |
| Mar 2021 | - | $74.70 K(-10.0%) | $314.60 K(+2.5%) |
| Dec 2020 | $306.80 K | $83.00 K(+5.2%) | $306.80 K(+10.5%) |
| Sep 2020 | - | $78.90 K(+1.2%) | $277.60 K(+9.2%) |
| Jun 2020 | - | $78.00 K(+16.6%) | $254.10 K(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $66.90 K(+24.3%) | $245.40 K(-3.8%) |
| Dec 2019 | $255.00 K(+80.0%) | $53.80 K(-2.9%) | $255.00 K(-0.6%) |
| Sep 2019 | - | $55.40 K(-20.1%) | $256.50 K(+8.8%) |
| Jun 2019 | - | $69.30 K(-9.4%) | $235.80 K(+22.9%) |
| Mar 2019 | - | $76.50 K(+38.3%) | $191.80 K(+35.4%) |
| Dec 2018 | $141.70 K(+76.5%) | $55.30 K(+59.4%) | $141.70 K(+31.1%) |
| Sep 2018 | - | $34.70 K(+37.2%) | $108.10 K(+14.5%) |
| Jun 2018 | - | $25.30 K(-4.2%) | $94.40 K(+7.0%) |
| Mar 2018 | - | $26.40 K(+21.7%) | $88.20 K(+9.8%) |
| Dec 2017 | $80.30 K(+42.1%) | $21.70 K(+3.3%) | $80.30 K(-12.1%) |
| Sep 2017 | - | $21.00 K(+9.9%) | $91.40 K(+14.8%) |
| Jun 2017 | - | $19.10 K(+3.2%) | $79.60 K(+15.0%) |
| Mar 2017 | - | $18.50 K(-43.6%) | $69.20 K(+22.3%) |
| Dec 2016 | $56.50 K(+378.8%) | $32.80 K(+256.5%) | $56.60 K(+137.8%) |
| Sep 2016 | - | $9200.00(+5.7%) | $23.80 K(+63.0%) |
| Jun 2016 | - | $8700.00(+47.5%) | $14.60 K(+147.5%) |
| Mar 2016 | - | $5900.00 | $5900.00 |
| Dec 2015 | $11.80 K | - | - |
FAQ
- What is Ovid Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Ovid Therapeutics?
- What is Ovid Therapeutics annual D&A year-on-year change?
- What is Ovid Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly D&A year-on-year change?
- What is Ovid Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Ovid Therapeutics?
- What is Ovid Therapeutics TTM D&A year-on-year change?
What is Ovid Therapeutics annual depreciation & amortization?
The current annual D&A of OVID is $1.60 M
What is the all time high annual D&A for Ovid Therapeutics?
Ovid Therapeutics all-time high annual depreciation & amortization is $1.60 M
What is Ovid Therapeutics annual D&A year-on-year change?
Over the past year, OVID annual depreciation & amortization has changed by +$215.00 K (+15.56%)
What is Ovid Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of OVID is $169.00 K
What is the all time high quarterly D&A for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly depreciation & amortization is $1.17 M
What is Ovid Therapeutics quarterly D&A year-on-year change?
Over the past year, OVID quarterly depreciation & amortization has changed by -$999.60 K (-85.54%)
What is Ovid Therapeutics TTM depreciation & amortization?
The current TTM D&A of OVID is $1.62 M
What is the all time high TTM D&A for Ovid Therapeutics?
Ovid Therapeutics all-time high TTM depreciation & amortization is $1.71 M
What is Ovid Therapeutics TTM D&A year-on-year change?
Over the past year, OVID TTM depreciation & amortization has changed by +$25.00 K (+1.57%)